marianne-riviere

Présentation Naimah Zein

Chers adhérents, chers amis,Etant Docteure en Biologie Moléculaire et Cellulaire, diplômée de l’université de Strasbourg en décembre 2018, j’ai réalisé mes travaux de recherche à l’Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) sous la direction de Pr. Pierre Chambon. Ce GRAND Homme est l’un des chercheurs français de très grande Renommée mondiale […]

Présentation Naimah Zein Lire la suite »

The Antiphospholipid Antibody Syndrome (« SAPL »)

The Antiphospholipid antibody syndrome (« SAPL ») is an autoimmune « disease » characterized  clinically by the occurence of blood clots or miscariages  and biologically by the presence of antibodies directed against phospholipids. Phospholipid are constituent of our  cell membranes. By interacting with some membranes, these antibodies will activate coagulation and cause the appearance of blood clots (thrombosis), which can be located in all body’s blood vessels

The Antiphospholipid Antibody Syndrome (« SAPL ») Lire la suite »

Cardiovascular risk and systemic lupus erythematosus

Introduction and Epidemiology Atherosclerosis during lupus is an important issue because of its major impact in terms of morbi-mortality and prognosis. The last years are by the understanding of new pathophysiological mechanisms of atherosclerosis in connective which led to new therapeutic concepts. However, several questions remain unanswered about the particular mechanisms responsible for the accelerated

Cardiovascular risk and systemic lupus erythematosus Lire la suite »

The first National Survey about prevalence of Lupus in France

The first National Survey about the prevalence of Lupus in France For the first time, a survey using national data of health (“SNIIRAM and PMSI) allowed to estimate the incidence and prevalence of systemic lupus erythematosus, in France, in respectively 3,32 and 47 case/100 000 year 2010, and 27369 prevalent cases the same year. The

The first National Survey about prevalence of Lupus in France Lire la suite »

We want (have the right) to work !

Chronic diseases and professional life Many people with a chronic disease work or want to work. However, people affected by these diseases are still too often outside of any professional activity, either because they are unfamiliar with the integration structures and devices maintaining employment, either because operators insertion and employers don’t have at their disposal

We want (have the right) to work ! Lire la suite »

Recommendations of Oral Health for patients with Scleroderma Systemic

Juliette ROCHEFORT1, Yvon Roche1, Adrian Hij2, D. Farge2, Arnaud Rigolet3   Unit of dentistry, Rothschild Hospital, Paris, France Unit of Internal Médicine and Vascular Pathology, St Louis Hospital, Paris, France Unit of Stomatology and Maxillofacial, St Louis Hospital, Paris, France The Scleroderma Systemic(SSc) is a disease of connective tissue. Initiated by an endothelial injury, it’s characterized

Recommendations of Oral Health for patients with Scleroderma Systemic Lire la suite »

Renal Involvement in Systemic Lupus Erythematosus

Introduction The kidneys filter the blood and remove the waste product in the urine. Small kidney filters, called « glomeruli », let through water, salt and waste, but don’t let the albumin and blood cells. In the systemic lupus erythematosus, glomeruli can be damaged by the deposit of antibodies and by an inflammatory of up destruction. It let go

Renal Involvement in Systemic Lupus Erythematosus Lire la suite »